STALEVO is a combination of carbidopa, levodopa, and entacapone
for the treatment of Parkinson's disease and patients with end-of-dose wearing-off. STALEVO Snapshot
Read our detail aid, which contains information on efficacy, safety, dosing,
and other product information
Who Is Appropriate For STALEVO
Read information about the type of patients who may benefit from treatment with STALEVO
Dosing
Read information on the appropriate dosing for STALEVO
Safety & Efficacy
Read information on the safety and efficacy of STALEVO
Mechanism of Action
Information on the pharmacokinetics of STALEVO
Please see Important Safety Information.
|
